Top Buy
| Wertpapier | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | 28,00 € | 47,53 € | 69,74 % |
| Incyte Corp. | 12 | 2 | 3 | 0 | 52,74 € | 78,42 € | 48,70 % |
| Resmed Inc. | 19 | 0 | 3 | 0 | 199,45 € | 203,18 € | 1,87 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 19,41 € | 26,01 € | 33,98 % |
| ProQR Therapeutics N.V. | 8 | 1 | 3 | 1 | 1,83 € | 3,03 € | 65,90 % |
| United Therapeutics | 18 | 0 | 3 | 0 | 249,20 € | 288,66 € | 15,83 % |
| XOMA Corp. | 6 | 0 | 3 | 0 | 22,60 € | 68,78 € | 204,33 % |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | 368,60 € | 421,61 € | 14,38 % |
| Krystal Biotech | 17 | 0 | 3 | 0 | 145,65 € | 179,60 € | 23,31 % |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | 103,55 € | 184,92 € | 78,58 % |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | 40,50 € | 50,33 € | 24,28 % |
| LivaNova plc | 9 | 0 | 3 | 0 | 56,00 € | 66,59 € | 18,92 % |
| Evolus Inc | 9 | 0 | 3 | 0 | 11,60 € | 20,43 € | 76,14 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | 38,00 € | 84,74 € | 123,01 % |
| Icon plc | 18 | 0 | 3 | 0 | 287,00 € | 319,67 € | 11,38 % |
| Pfizer Inc. | 30 | 4 | 3 | 0 | 26,23 € | 40,66 € | 55,04 % |
| Galmed Pharmaceuticals Ltd. | 7 | 0 | 3 | 0 | 0,37 € | 63,93 € | 16993,85 % |
| Atossa Genetics Inc | 7 | 1 | 3 | 0 | 1,45 € | 3,74 € | 158,26 % |
| Centene Corp. | 15 | 0 | 3 | 0 | 71,48 € | 82,57 € | 15,52 % |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | 8,65 € | 17,78 € | 105,54 % |
| Select Medical Holdings | 6 | 0 | 3 | 0 | 31,20 € | 36,41 € | 16,69 % |
| Twist Bioscience Corp | 7 | 0 | 3 | 0 | 44,49 € | 41,65 € | -6,39 % |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | 2,58 € | 4,58 € | 77,68 % |
| Johnson & Johnson | 32 | 1 | 3 | 0 | 139,90 € | 196,74 € | 40,63 % |
| Humana Inc. | 23 | 0 | 3 | 0 | 318,30 € | 439,88 € | 38,20 % |